| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,380.00
|
|
Change (%)
|
-1.00 (-0.07%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,372.00
-
1,386.50
|
|
52-Week Range (RS)
|
1,165.55
-
1,672.20
|
|
Beta (1 Year)
|
0.54
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| Cipla receives ESG rating of 68 |
| Invagen Pharmaceuticals enters licensing agreement with Qilu |
| Cipla inks exclusive partnership with Qilu Pharma for commercializing Pembrolizumab in US |
| Cipla inks exclusive licensing agreement with SBP Group for ADC Rolditamig Deuderuxtecan |
| Cipla and SBP Group sign exclusive license agreement for Rolditamig Deuderuxtecan |
| InvaGen receives EIR report for its facility in Hauppauge, New York |
| Cipla consolidated net profit declines 39.19% in the June 2026 quarter |
| Cipla drops after Q1 PAT tumbles 39% YoY to Rs 789 cr |
| Board of Cipla approves change in senior management |
| Cipla grants 24,709 stock options and ESARs |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
15-Sep-2026 |
1361.00 |
1.47 |
| 1Month |
24-Aug-2026 |
1435.00 |
-3.76 |
| 3Month |
22-Jun-2026 |
1415.30 |
-2.42 |
| 6Month |
23-Mar-2026 |
1222.70 |
12.95 |
| 1Year |
22-Sep-2025 |
1541.70 |
-10.42 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
2.47 |
2804.65 |
| Parag Parikh Flexi Cap Fund |
1.37 |
2022.43 |
| SBI Nifty 50 ETF |
0.72 |
1538.04 |
| ICICI Pru Value Fund |
1.30 |
782.02 |
| SBI ELSS Tax Saver Fund |
2.11 |
670.31 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,865.00 |
1.14 |
2,047.55 |
1,547.25 |
442,437.37 |
| Zydus Lifesciences Ltd |
1,169.50 |
0.73 |
1,205.65 |
835.85 |
115,810.19 |
| Laurus Labs Ltd |
2,034.80 |
1.48 |
2,032.50 |
822.85 |
108,338.00 |
| Mankind Pharma Ltd |
2,462.50 |
-0.68 |
2,670.00 |
1,909.90 |
102,410.40 |
| Dr Reddys Laboratories Ltd |
1,210.10 |
-0.16 |
1,414.40 |
1,080.05 |
101,163.25 |
|
|
|
|